Condition
Adenocarcinoma of the Rectum clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Adenocarcinoma of the Rectum clinical trials that are recruiting, at sites in 3 countries (most in United States (5), United Kingdom (1), Puerto Rico (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Adenocarcinoma of the Rectum clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Understanding how rectal cancer responds to standard treatment before surgery | — | Middletown, New Jersey and 5 other locations | Recruiting | Oct 15, 2024 |
| Combining Tucatinib and Trastuzumab for HER2 Positive Rectal Cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Jan 5, 2023 |
| Comparing 5-year and 10-year colonoscopy schedules for patients with non-advanced adenomas | — | Fairbanks, Alaska and 498 other locations | Recruiting | Oct 18, 2021 |
| Biopsy to study tumor changes after radioembolization | — | New York, New York | Recruiting | Dec 16, 2020 |
| Testing stool samples for cancer detection in colorectal cancer survivors | — | Cleveland, Ohio | Recruiting | Nov 12, 2020 |
| Improving diagnosis of rectal cancer using imaging techniques | — | London, Surrey | Recruiting | Oct 6, 2017 |
All recruiting trials (6)
-
Understanding how rectal cancer responds to standard treatment before surgery
This study is testing how well standard treatments for rectal cancer work before surgery to see if they can help predict how the cancer will change.
-
Combining Tucatinib and Trastuzumab for HER2 Positive Rectal Cancer
This study is testing if combining two cancer drugs, tucatinib and trastuzumab, with standard chemotherapy can help people with HER2 positive rectal cancer have better treatment results.
-
Comparing 5-year and 10-year colonoscopy schedules for patients with non-advanced adenomas
This study is testing whether people with 1 to 2 non-advanced polyps can safely have colonoscopies every 10 years instead of every 5 years without raising their risk of colorectal cancer.
-
Biopsy to study tumor changes after radioembolization
This study is trying to see how tumors in patients with colorectal cancer that has spread to the liver change after they receive a specific radiation treatment called radioembolization.
-
Testing stool samples for cancer detection in colorectal cancer survivors
This study is testing if a new stool test can help find polyps and cancer in colorectal cancer survivors to see if it works better than regular check-ups.
-
Improving diagnosis of rectal cancer using imaging techniques
This study is testing whether using advanced MRI techniques can help doctors better identify rectal cancer before surgery to improve treatment outcomes for patients.
Related topics
Quick answers
How many Adenocarcinoma of the Rectum clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (5 trials), United Kingdom (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.